These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38069034)

  • 61. Epstein-Barr Virus LMP1-Activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell Properties.
    Zhu N; Wang Q; Wu Z; Wang Y; Zeng MS; Yuan Y
    J Virol; 2022 Mar; 96(5):e0194121. PubMed ID: 35019715
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Benchmarking effects of mTOR, PI3K, and dual PI3K/mTOR inhibitors in hepatocellular and renal cell carcinoma models developing resistance to sunitinib and sorafenib.
    Serova M; de Gramont A; Tijeras-Raballand A; Dos Santos C; Riveiro ME; Slimane K; Faivre S; Raymond E
    Cancer Chemother Pharmacol; 2013 May; 71(5):1297-307. PubMed ID: 23479136
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.
    Zhang Z; Zhu J; Huang Y; Li W; Cheng H
    Diagn Pathol; 2018 Nov; 13(1):85. PubMed ID: 30390677
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition.
    Umemura A; Park EJ; Taniguchi K; Lee JH; Shalapour S; Valasek MA; Aghajan M; Nakagawa H; Seki E; Hall MN; Karin M
    Cell Metab; 2014 Jul; 20(1):133-44. PubMed ID: 24910242
    [TBL] [Abstract][Full Text] [Related]  

  • 65. mTOR direct crosstalk with STAT5 promotes de novo lipid synthesis and induces hepatocellular carcinoma.
    Li T; Weng J; Zhang Y; Liang K; Fu G; Li Y; Bai X; Gao Y
    Cell Death Dis; 2019 Aug; 10(8):619. PubMed ID: 31409773
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth.
    Yin S; Liu L; Ball LE; Wang Y; Bedford MT; Duncan SA; Wang H; Gan W
    Cell Rep; 2023 Apr; 42(4):112316. PubMed ID: 36995937
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlation of LAGE3 with unfavorable prognosis and promoting tumor development in HCC via PI3K/AKT/mTOR and Ras/RAF/MAPK pathways.
    Li Y; Xiong H
    BMC Cancer; 2022 Mar; 22(1):298. PubMed ID: 35313850
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PEBP4 Directs the Malignant Behavior of Hepatocellular Carcinoma Cells via Regulating mTORC1 and mTORC2.
    Chen Q; Jin J; Guo W; Tang Z; Luo Y; Ying Y; Lin H; Luo Z
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955931
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of mTORC1 induces loss of E-cadherin through AKT/GSK-3β signaling-mediated upregulation of E-cadherin repressor complexes in non-small cell lung cancer cells.
    Kim EY; Kim A; Kim SK; Kim HJ; Chang J; Ahn CM; Chang YS
    Respir Res; 2014 Feb; 15(1):26. PubMed ID: 24571487
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice.
    Wang C; Cigliano A; Jiang L; Li X; Fan B; Pilo MG; Liu Y; Gui B; Sini M; Smith JW; Dombrowski F; Calvisi DF; Evert M; Chen X
    Hepatology; 2015 Jan; 61(1):200-13. PubMed ID: 25145583
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.
    Park YY; Sohn BH; Johnson RL; Kang MH; Kim SB; Shim JJ; Mangala LS; Kim JH; Yoo JE; Rodriguez-Aguayo C; Pradeep S; Hwang JE; Jang HJ; Lee HS; Rupaimoole R; Lopez-Berestein G; Jeong W; Park IS; Park YN; Sood AK; Mills GB; Lee JS
    Hepatology; 2016 Jan; 63(1):159-72. PubMed ID: 26389641
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma.
    Yen CJ; Lin YJ; Yen CS; Tsai HW; Tsai TF; Chang KY; Huang WC; Lin PW; Chiang CW; Chang TT
    PLoS One; 2012; 7(7):e41931. PubMed ID: 22848663
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway.
    Wang SS; Chen YH; Chen N; Wang LJ; Chen DX; Weng HL; Dooley S; Ding HG
    Cell Death Dis; 2017 Mar; 8(3):e2688. PubMed ID: 28333142
    [TBL] [Abstract][Full Text] [Related]  

  • 75. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
    Lei T; Zhu X; Zhu K; Jia F; Li S
    Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma.
    Rahmani F; Ziaeemehr A; Shahidsales S; Gharib M; Khazaei M; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
    J Cell Physiol; 2020 May; 235(5):4146-4152. PubMed ID: 31663122
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sialyltransferase ST3GAL6 mediates the effect of microRNA-26a on cell growth, migration, and invasion in hepatocellular carcinoma through the protein kinase B/mammalian target of rapamycin pathway.
    Sun M; Zhao X; Liang L; Pan X; Lv H; Zhao Y
    Cancer Sci; 2017 Feb; 108(2):267-276. PubMed ID: 27906498
    [TBL] [Abstract][Full Text] [Related]  

  • 78. eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway.
    Sun L; Liu S; Wang X; Zheng X; Chen Y; Shen H
    J Transl Med; 2021 May; 19(1):216. PubMed ID: 34016142
    [TBL] [Abstract][Full Text] [Related]  

  • 79. METTL3 expression is associated with glycolysis metabolism and sensitivity to glycolytic stress in hepatocellular carcinoma.
    Lin Y; Wei X; Jian Z; Zhang X
    Cancer Med; 2020 Apr; 9(8):2859-2867. PubMed ID: 32068977
    [TBL] [Abstract][Full Text] [Related]  

  • 80. SNRPD1 inhibition suppresses the proliferation of hepatocellular carcinoma and promotes autophagy through the PI3K/AKT/mTOR/4EBP1 pathway.
    Wang H; Chen M; Yang C; Hu H; Jiang Y; Yang F; Lv L
    Arch Biochem Biophys; 2023 Jul; 743():109661. PubMed ID: 37268273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.